Verici Dx – emphasises “Certificate of Compliance”, but what’s the financial outlook?
Previously writing on transplant platform company Verici Dx (VRCI), in September with the shares falling to 17.5p I reviewed was the fundraise for accelerated progress or to avert cash crunch ahoy?, concluding continue to avoid. The shares most recently closed at 7.5p, but what of them currently up 20% today on the back of a “CLIA Certificate of Compliance” announcement.
- By Steve Moore
- 2023-03-02 14:01:59